Payment overview · 2025
General Payments
$26.84
1 reported records · 1 companies
Healthcare provider profile · identity verified
Michael Stephen Fitzpatrick, D.O.
Allopathic & Osteopathic Physicians|Family Medicine · GREENCASTLE, PA · NPI 1043233695
Verified facts
What the public records show
CMS Open Payments records show Michael Stephen Fitzpatrick, D.O. received $26.84 in general payments during 2025 across 1 reported records.
Boston Scientific Corporation accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Boston Scientific Corporation | Unresolved — no canonical attribution shown | $26.84 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $26.84 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| WaveWriter Alpha Prime 16 Normalized: wavewriter alpha prime 16 |
Device | Boston Scientific Corporation | $26.84 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 538 | 149 |
| Lisinopril | Lisinopril | 443 | 126 |
| Amlodipine Besylate | Amlodipine Besylate | 376 | 98 |
| Metoprolol Succinate | Metoprolol Succinate | 323 | 83 |
| Levothyroxine Sodium | Levothyroxine Sodium | 306 | 73 |
| Hydrochlorothiazide | Hydrochlorothiazide | 289 | 83 |
| Omeprazole | Omeprazole | 246 | 63 |
| Pantoprazole Sodium | Pantoprazole Sodium | 242 | 62 |
| Metformin Hcl | Metformin Hcl | 215 | 52 |
| Gabapentin | Gabapentin | 200 | 47 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 185 | 60 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 155 | 36 |
| Losartan Potassium | Losartan Potassium | 148 | 41 |
| Furosemide | Furosemide | 145 | 45 |
| Escitalopram Oxalate | Escitalopram Oxalate | 139 | 38 |
| Tamsulosin Hcl | Tamsulosin Hcl | 138 | 40 |
| Spironolactone | Spironolactone | 125 | 29 |
| Clopidogrel | Clopidogrel Bisulfate | 123 | 30 |
| Pravastatin Sodium | Pravastatin Sodium | 122 | 35 |
| Metformin Hcl Er | Metformin Hcl | 112 | 34 |
| Metoprolol Tartrate | Metoprolol Tartrate | 112 | 28 |
| Sertraline Hcl | Sertraline Hcl | 103 | 27 |
| Duloxetine Hcl | Duloxetine Hcl | 101 | 24 |
| Famotidine | Famotidine | 98 | 30 |
| Donepezil Hcl | Donepezil Hcl | 97 | 22 |
| Memantine Hcl | Memantine Hcl | 96 | 17 |
| Eliquis | Apixaban | 94 | 26 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 91 | 21 |
| Allopurinol | Allopurinol | 85 | 25 |
| Finasteride | Finasteride | 85 | 22 |
| Jardiance | Empagliflozin | 84 | 17 |
| Potassium Chloride | Potassium Chloride | 84 | 23 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 83 | 35 |
| Valsartan | Valsartan | 83 | 19 |
| Fluticasone Propionate | Fluticasone Propionate | 82 | 29 |
| Pioglitazone Hcl | Pioglitazone Hcl | 82 | 22 |
| Carvedilol | Carvedilol | 79 | 24 |
| Celecoxib | Celecoxib | 74 | 20 |
| Tramadol Hcl | Tramadol Hcl | 73 | 28 |
| Trazodone Hcl | Trazodone Hcl | 71 | 20 |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 66 | 66 |
| Simvastatin | Simvastatin | 66 | 20 |
| Meloxicam | Meloxicam | 65 | 24 |
| Buspirone Hcl | Buspirone Hcl | 64 | 14 |
| Ozempic | Semaglutide | 63 | 11 |
| Montelukast Sodium | Montelukast Sodium | 62 | 17 |
| Citalopram Hbr | Citalopram Hydrobromide | 61 | 12 |
| Atenolol | Atenolol | 60 | 16 |
| Zolpidem Tartrate | Zolpidem Tartrate | 56 | 21 |
| Adacel Tdap | Diph,pertuss(Acell),tet Vac/Pf | 54 | 54 |
| Mounjaro | Tirzepatide | 54 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 54 | 29 |
| Glipizide Er | Glipizide | 53 | 14 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 50 | suppressed |
| Prednisone | Prednisone | 49 | 31 |
| Bupropion Xl | Bupropion Hcl | 48 | 12 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 46 | suppressed |
| Clonazepam | Clonazepam | 43 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 43 | 23 |
| Lorazepam | Lorazepam | 43 | 15 |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 43 | 35 |
| Sod Sulf-Potass Sulf-Mag Sulf | Sodium, Potassium,mag Sulfates | 43 | 43 |
| Spironolactone-Hctz | Spironolact/Hydrochlorothiazid | 42 | 12 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 42 | 11 |
| Synthroid | Levothyroxine Sodium | 41 | 14 |
| Cephalexin | Cephalexin | 40 | 30 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 40 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 38 | suppressed |
| Pregabalin | Pregabalin | 34 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 33 | 11 |
| Fluoxetine Hcl | Fluoxetine Hcl | 33 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 33 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 32 | 15 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 32 | 11 |
| Warfarin Sodium | Warfarin Sodium | 31 | 11 |
| Alprazolam | Alprazolam | 30 | 11 |
| Breo Ellipta | Fluticasone/Vilanterol | 30 | suppressed |
| Glimepiride | Glimepiride | 30 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 30 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 29 | suppressed |
| Glipizide | Glipizide | 28 | suppressed |
| Ondansetron Odt | Ondansetron | 28 | 11 |
| Alendronate Sodium | Alendronate Sodium | 27 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 27 | suppressed |
| Irbesartan | Irbesartan | 26 | suppressed |
| Chlorthalidone | Chlorthalidone | 25 | suppressed |
| Januvia | Sitagliptin Phosphate | 25 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 24 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 23 | suppressed |
| Mirtazapine | Mirtazapine | 23 | suppressed |
| Nystatin | Nystatin | 23 | 12 |
| Oxycodone Hcl | Oxycodone Hcl | 23 | 12 |
| Paroxetine Hcl | Paroxetine Hcl | 23 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 23 | suppressed |
| Ramipril | Ramipril | 23 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 23 | suppressed |
| Trulicity | Dulaglutide | 23 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 22 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 22 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 22 | suppressed |
| Novolog Flexpen | Insulin Aspart | 21 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 20 | 16 |
| Ibuprofen | Ibuprofen | 20 | suppressed |
| Lamotrigine | Lamotrigine | 20 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 19 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 19 | suppressed |
| Lactulose | Lactulose | 19 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 19 | 11 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 18 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 18 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 18 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 18 | suppressed |
| Ezetimibe | Ezetimibe | 18 | suppressed |
| Amoxicillin | Amoxicillin | 17 | 15 |
| Divalproex Sodium | Divalproex Sodium | 17 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 17 | suppressed |
| Fenofibrate | Fenofibrate | 17 | suppressed |
| Icosapent Ethyl | Icosapent Ethyl | 17 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 17 | suppressed |
| Azithromycin | Azithromycin | 16 | 12 |
| Benazepril Hcl | Benazepril Hcl | 16 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 16 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 16 | 13 |
| Meclizine Hcl | Meclizine Hcl | 16 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 16 | suppressed |
| Primidone | Primidone | 16 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 15 | suppressed |
| Rabeprazole Sodium | Rabeprazole Sodium | 15 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 14 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 14 | suppressed |
| Pindolol | Pindolol | 14 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 14 | suppressed |
| Bumetanide | Bumetanide | 13 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 13 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 13 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 13 | suppressed |
| Imipramine Hcl | Imipramine Hcl | 13 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 13 | suppressed |
| Xarelto | Rivaroxaban | 13 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 12 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 12 | suppressed |
| Invokana | Canagliflozin | 12 | suppressed |
| Rybelsus | Semaglutide | 12 | suppressed |
| Trospium Chloride | Trospium Chloride | 12 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 11 | 11 |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 11 | suppressed |
| Candesartan Cilexetil | Candesartan Cilexetil | 11 | suppressed |
| Estradiol | Estradiol | 11 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 11 | suppressed |
| Torsemide | Torsemide | 11 | suppressed |
| Xifaxan | Rifaximin | 11 | suppressed |
| Xtampza Er | Oxycodone Myristate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $26.84 · 1 records | Boston Scientific Corporation | WaveWriter Alpha Prime 16 | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error